JINGHAO MEDICAL
872925
TONGYI AEROSPACE
871642
ESKONJAC
839273
4
Jiangsu Olive Sensors High-Tech
300507
5
Jing-Jin Electric Technologies
688280
Denali Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of a portfolio of product candidates for neurodegenerative diseases. Its product pipeline includes LRRK2, RIPK1, TREM2, and Tau. The company was founded by Ryan J. Watts, Marc Tessier-Lavigne, and Alexander Schuth on October 14, 2013 and is headquartered in San Francisco, CA.